Preterm very low birthweight (below or equal 1500 g) · pregnant women presenting for routine prenatal care
Lower genital tract infection screening probably leads to lower preterm very low birthweight (below or equal 1500 g) compared with no screening (moderate certainty).
1 finding from 1 review
Serum calcium · people with CKD‐MBD
1 finding from 1 review
Alkaline phosphatase · people with CKD‐MBD
1 finding from 1 review
All‐cause mortality · people with CKD‐MBD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cardiovascular events · people with CKD‐MBD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Fracture · people with CKD‐MBD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serum phosphorus · people with CKD‐MBD
1 finding from 1 review
PTH · people with CKD‐MBD
1 finding from 1 review
Death (all causes) · non‐diabetic adults with CKD
Very low protein diet showed no clear difference in death (all causes) compared with low or normal protein diet (moderate certainty).
1 finding from 1 review
ESKD · non‐diabetic adults with CKD
Very low protein diet probably leads to lower ESKD compared with low or normal protein diet (moderate certainty).
1 finding from 1 review
End or change in GFR · non‐diabetic adults with CKD
1 finding from 1 review
Global state: clinically important change in global state · patients with schizophrenia
1 finding from 1 review
Mental state: clinically important response, as defined by individual studies * · patients with schizophrenia
1 finding from 1 review
Functioning: clinically important change in general functioning, as defined by individual studies · patients with schizophrenia
1 finding from 1 review
Adverse effect: clinically important adverse effect (weight ‐ BMI) · patients with schizophrenia
1 finding from 1 review
Service utilisation outcomes: hospital admission or days in hospital · patients with schizophrenia
1 finding from 1 review
Service use: time to hospitalisation · patients with schizophrenia
1 finding from 1 review
Quality of life: clinically important change in quality of life · patients with schizophrenia
1 finding from 1 review
Clinical response: mental state ‐ relapse ‐ medium term Relapse rate · patients with schizophrenia or related psychoses
FLUPENTHIXOL DECANOATE VERY LOW (˜6 mg/IM) DOSE showed no clear difference in clinical response: mental state ‐ relapse ‐ medium term Relapse rate compared with FLUPENTHIXOL DECANOATE LOW DOSE (˜9 mg/IM) (low certainty).
1 finding from 1 review
Mental state · patients with schizophrenia or related psychoses
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found